News

Can monoclonal antibodies effectively treat malaria? Scientists say the answer is a resounding 'yes'
Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant ...
Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia
Lundbeck today announces that orphan drug designation has been granted to Lu AG13909 by the US Food and Drug Administration (FDA) on 12 May 2025 and the European Medicines Agency (EMA) on 20 June 2025 ...
Liminatus Pharma: CD47 Hasn't Worked For Anyone, But Is This The Exception?
Liminatus Pharma is a preclinical oncology company focused on a CD47 antibody. Check out why I see little reason for ...
Science Daily1h
COVID-19 protein triggers immune attacks on healthy cells — but a common drug can stop it
Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...
Applied Clinical Trials Online2h
MariTide Shows Up to 20% Weight Loss in Phase II Trial for Obesity, Type 2 Diabetes
In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...
PMLive6h
AstraZeneca/Daiichi Sankyo’s Datroway granted FDA accelerated approval for lung cancer
AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been granted accelerated approval by the US Food ...
News-Medical.Net on MSN21h
Bispecific antibodies offer new hope for resistant NSCLC patients
As the leading cause of cancer-related death, lung cancer remains a noteworthy hazard to human health. NSCLC is the most ...
What to expect from CDC vaccine advisory committee meeting with RFK Jr.'s new members
The CDC's vaccine advisory committee is set to meet for the first time since HHS Secretary Robert F. Kennedy Jr. dismissed ...
Pharmabiz7h
Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer
Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer: Our Bureau, Mumbai Tuesday, June 24, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Ltd, a research ...
PharmTech4h
Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
PharmiWeb7m
New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine
The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant ...